Physician

Pathology

Dr. Vasiliki Leventaki, MD

Dr. Vasiliki Leventaki works in the field of Pathology. Vasiliki Leventaki is a published doctor as well. She has 23 publications published. The latest was: TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of cases.

Publications

TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of cases.
Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma.
Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair.
Yolk Sac Tumor of the Thyroid Gland: A Case Report.
Expression of serine 194-phosphorylated Fas-associated death domain protein correlates with proliferation in B-cell non-Hodgkin lymphomas.
mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells.
Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with r...
Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation.
The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma.
NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma.
c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders.
Differential expression of the human MIXL1 gene product in non-Hodgkin and Hodgkin lymphomas.
Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.
Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
c-FLIP confers resistance to FAS-mediated apoptosis in anaplastic large-cell lymphoma.
Re: Rust et al. TIMP-1 expression in anaplastic large cell lymphoma is usually restricted to macrophages and only seldom observed in tumour cells. J Pathol 2005;206:44...
Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma.
Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma.
Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma.
Characterization of 4 mantle cell lymphoma cell lines.
Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours.

Doctors Specialties

Hematology
Hematopathology
Pathology

Accepted Insurances

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Robert C. Blaylock, MD This Doctor is OpenDoctor Recommended.
	Dr. Josef T. Prchal, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Attila Kumanovics, MD This Doctor is OpenDoctor Recommended.
	Dr. Gerald S. Rothstein, MD
	Dr. Kristi J. Smock, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Lyska L. Emerson, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Christine M. Litwin, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Lester J. Layfield, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Nahla M. Heikal, MD This Doctor is OpenDoctor Recommended.
	Dr. Djordje Atanackovic, MD This Doctor is OpenDoctor Recommended.
	Dr. Jay L. Patel, MD
	Dr. John W. Sweetenham, MD This Doctor is OpenDoctor Recommended.